On January 17, 2012 the FDA announced an opportunity for public comment on its Healthcare Professional Survey of Prescription Drug Promotion. This survey is designed to explore the opinions and perceptions of physicians, nurse practitioners, and physician assistants with regard to the promotion of prescription drugs to consumers and healthcare providers. FDA is inviting comments on, among other things, the necessity of the information collection, ways to enhance the utility of the information to be collected, and ways to minimize the burden of the collection of information on respondents. Comments will be accepted until March 19, 2012.